Epic's AI push pressures health tech startup. Table of contents. Epic showed off its continued expansion of AI for clinicians and patients at its annual Users Group Meeting this week, putting pressure on health tech startups even as the company confronts what may be its most consequential year yet, marked by a reported Epic UGM 2026 FTC antitrust investigation, executive departures, and mounting legal challenges. The scale and setting behind Epic UGM 2026 FTC antitrust scrutiny. News of the FTC probe comes as Epic's annual Users Group Meeting kicks off this week at its headquarters in Verona, Wisconsin, drawing an estimated 20,000 attendees, including health system and health tech executives. Every August, Epic founder Judy Faulkner holds court with this crowd in an auditorium buried five stories into the Wisconsin earth, unveiling innovations that inevitably form a technological road map for America's hospitals. Why this year's meeting carries added weight. The company Faulkner founded nearly half a century ago, now the nation's dominant seller of electronic health records software, is facing an unprecedented series of challenges driven by antitrust lawsuits, questions about its artificial intelligence strategy, an exodus of key technology leaders, and, most recently, the disclosure that state and federal investigators are looking into the company's business practices. What the FTC is reportedly investigating within this Epic UGM 2026 FTC antitrust probe. Federal investigators are reportedly probing Epic on two fronts: its employment agreements that restrict workers from joining a broad range of competing healthcare companies, and allegations that it has used its market dominance to limit rivals' access to patient data needed to operate and compete, according to STAT's reporting citing four people who were recently contacted by investigators. The scope of Epic's market position. Epic handles the electronic medical records for 57% of inpatient hospital beds in America, and approximately 82% of Americans have at least one record stored by Epic, whose annual revenue was $5.7 billion in 2024, up from $3.3 billion in 2020, according to reporting on the company's scale. Private lawsuits preceding this Epic UGM 2026 FTC antitrust investigation. The increasing interest of federal investigators in the company follows the filing of several private lawsuits against Epic by rival businesses and former employees. A 2025 lawsuit from CureIS Healthcare, a company that makes software for managed care organizations, alleges that Epic began blocking its access to data held within customers' own instances of Epic, part of a playbook it says the company uses to undercut third-party solutions. The Particle Health and Texas Attorney General cases. Epic separately accused data-sharing platform Particle Health of obtaining confidential patient medical records under pretenses, though a judge denied Epic's request to dismiss Particle's case, and it continues. In December, Texas Attorney General Ken Paxton sued Epic, alleging deceptive practices that undermine children's healthcare and violate the state's health and safety code, a suit Epic has moved to dismiss. Executive departures coinciding with this Epic UGM 2026 FTC antitrust scrutiny. As it faces down these lawsuits, several of Epic's top technology leaders have left the company in recent months, citing a variety of reasons. Sumit Rana, who was long rumored to be Faulkner's heir apparent, said in early July he was leaving the company for personal reasons. How Epic has responded. "Epic does more to support standards-based data-sharing than any other EHR vendor," an Epic spokesperson told Healthcare IT News in a written statement responding to the reported FTC scrutiny, pushing back against the characterization of the company's data access practices. Why Epic's AI expansion matters amid this Epic UGM 2026 FTC antitrust backdrop. Even as it navigates this legal and leadership turbulence, Epic continued expanding its AI portfolio at this year's meeting, broadening clinician- and patient-facing tools in ways that increasingly overlap with the offerings of health tech startups and established players alike, from ambient documentation competitors to companies like Wolters Kluwer building AI features into reference products like UpToDate. Why this overlap adds competitive pressure. By expanding further into functionality areas where startups and established health tech vendors already operate, Epic's continued AI buildout at UGM adds competitive pressure precisely at a moment when the company is simultaneously facing scrutiny over whether its market dominance has already limited rivals' ability to compete on a level playing field. What this Epic UGM 2026 FTC antitrust situation means going forward. With the FTC investigation reportedly examining both Epic's employment restrictions and its data-sharing practices, the outcome could have significant implications for how the dominant EHR vendor structures future competitor relationships and patient data access policies. Given the confluence of legal challenges, leadership departures, and continued AI expansion all playing out simultaneously, this period may prove to be a defining stretch for how Epic balances its market position against mounting regulatory and competitive pressure. What to watch going forward. As the FTC investigation continues and Epic works to fill leadership gaps left by departures like Rana's, industry observers will likely watch how Faulkner addresses these challenges directly in her UGM remarks and whether the company adjusts its data-sharing or employment practices in response to regulatory pressure. Given Epic's continued AI expansion overlapping with health tech startups' core offerings, this Epic UGM 2026 FTC antitrust situation may shape not only the company's own regulatory future but also the broader competitive dynamics of the health tech AI market heading into 2027.

Epic asks a federal court to dismiss Particle Health's antitrust lawsuit, saying that it's a revenge lawsuit that fails to prove anticompetitive behavior.